Sera Prognostics said this week that it has completed enrollment of 5,500 women in its Proteomic Assessment of Preterm Risk clinical study supporting the validation of its PreTRM proteomic test for predicting risk of preterm birth.

The company plans to have data from these samples in the fourth quarter of this year with launch of the test likely in 2014. The test had originally been slated for release in the fall of this year but will be delayed due to expansion of the PAPR trial size, the company told ProteoMonitor through a spokesperson.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.